サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1758971

フローダイバージョン動脈瘤治療の世界市場

Flow Diversion Aneurysm Treatment

出版日
ページ情報
英文 138 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
フローダイバージョン動脈瘤治療の世界市場
出版日: 2025年06月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 138 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

フローダイバージョン動脈瘤治療の世界市場は2030年までに82億米ドルに達する見込み

2024年に53億米ドルと推定されるフローダイバージョン動脈瘤治療の世界市場は、2024～2030年の分析期間にCAGR 7.7%で成長し、2030年には82億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるFlow-Diverting Stentsは、CAGR 6.4%を記録し、分析期間終了時には54億米ドルに達すると予測されます。嚢内血流攪乱装置セグメントの成長率は、分析期間中CAGR 10.5％と推定されます。

米国市場は14億米ドル、中国はCAGR7.6％で成長予測

米国のフローダイバージョン動脈瘤治療市場は、2024年に14億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.9％と6.7％と予測されています。欧州では、ドイツがCAGR約6.4％で成長すると予測されています。

世界の動脈瘤治療における血流転換- 主要動向と促進要因のまとめ

なぜ流路転換が頭蓋内動脈瘤の治療に変革をもたらすのか？

血流転換は頭蓋内動脈瘤の治療における画期的な技術として登場し、特に従来のクリッピングやコイリング法では課題となる広頚部、大動脈瘤、瘤状動脈瘤、従来は治療不可能であった動脈瘤に有効です。動脈瘤嚢を直接塞ぐ従来の血管内コイリングとは異なり、フローダイバータは親動脈内に留置されたステント状のデバイスで、血流を動脈瘤から遠ざける。これにより動脈瘤内血栓と血管のリモデリングが促進され、動脈瘤壁は徐々に閉塞し、長期的に安定化します。

この方法の低侵襲性と複雑な未破裂動脈瘤に対する有効性とが相まって、流路転換術は神経インターベンションにおける好ましい戦略として位置づけられています。その良好な長期予後，再治療率の低下，内頸動脈のような課題解剖学的領域への適用可能性についての認識が高まり，臨床的採用が急増しています。神経学的画像診断とインターベンションの能力が進化するにつれて、特に以前は手術不可能と考えられていた動脈瘤に対して、流路転換術が早期の治療計画に組み込まれつつあります。

フローダイバーターの有効性と安全性を高める技術革新とは？

フローダイバーターのデザインと送達システムにおける技術的進歩は、手技の治療成績と安全性プロファイルの改善に重要な役割を果たしています。最新世代のフローダイバータは、より細いマイクロカテーテルに適合する薄型のシステムを特徴としており、曲がりくねった頭蓋内血管系をより良好に通過できるようになっています。再シース可能で再位置決め可能なデバイスなどの革新的技術により、神経インターベンション専門医は展開時のコントロールがより容易になり、誤位置決めや血管損傷のリスクが軽減されます。

ホスホリルコリンや親水性ポリマーコーティングなどの表面改質や抗血栓性コーティングは、血液適合性を高め、長期の二重抗血小板療法への依存を減らすために採用されています。次世代のフローダイバーターの中には生体吸収性のものもあり、血管のリモデリングが達成されれば分解され、長期的なインプラントのリスクを最小限に抑えるように設計されています。さらに、3D回転血管造影やロードマップ透視を含む画像誘導ナビゲーションシステムは、デバイス設置の精度と信頼性を向上させています。これらの技術革新により、遠位血管や分岐点など、以前はアクセスできなかった場所やリスクの高い場所での動脈瘤治療が可能になってきています。

血流転換の需要を牽引しているのはどのような患者集団と臨床環境か？

血流転換は成人患者の未破裂頭蓋内動脈瘤、特に前方循環（内頸動脈など）に対して最も一般的に行われています。しかし、後方循環動脈瘤、コイリング後の再発動脈瘤、および同情的使用や先進施設のプロトコールに基づく一部の破裂動脈瘤の症例では、臨床的エビデンスの増加によりその使用が拡大しつつあります。このアプローチは、コイリングが効果的でない、あるいは技術的に困難な大きな動脈瘤や巨大動脈瘤の患者に特に有益です。

専門的な神経インターベンション治療能力を備えた3次および4次医療センターが主な採用施設であるが、トレーニングや機器の利用可能性が向上するにつれて、この手技は徐々に地域病院や市中病院にも普及しつつあります。偶発的な脳画像による無症候性動脈瘤の発見が増加したことも、流路転換を用いた早期介入に寄与しています。一方、人口の高齢化と脳卒中に対する意識の高まりにより、動脈瘤の早期発見と選択的治療が臨床的に支持され、対象となる患者層が拡大しています。

血流転換市場の成長を支える主な促進要因は何か？

フローダイバージョン動脈瘤治療市場の成長は、手技の有効性、臨床需要、製品革新に関連するいくつかの主要な要因によってもたらされます。主要な原動力は、高い閉塞率、再治療の必要性の低さ、良好な神経学的転帰を実証する、実臨床でのエビデンスや長期追跡データの蓄積の拡大です。神経インターベンションが、耐久性のある結果をもたらす低侵襲性のソリューションへとシフトする中、フローダイバージョンは臨床家と患者の両方の期待に合致しています。

これと並行して、デバイスの柔軟性、送達性、安全性の向上により、分流による治療が可能な動脈瘤の解剖学的範囲と複雑性が拡大しています。脳卒中および神経血管インターベンションのインフラへの投資の増加-特に新興国において-も、高度動脈瘤治療への幅広いアクセスを促進しています。さらに、機器メーカーや学術センターによる継続的なトレーニング、プロクター、認定プログラムが臨床導入を加速しています。これらの要因が相まって、流路転換術は次世代の脳動脈瘤管理の基礎となる技術として強化されつつあります。

セグメント

製品（流路転換ステント、嚢内流路転換デバイス）;エンドユース（病院エンドユース、専門クリニックエンドユース）

調査対象企業の例（全42件）

  • Acandis GmbH
  • BALT Group
  • Cardinal Health Inc.
  • Endologix LLC
  • Evasc Medical Systems Corp.
  • Imperative Care Inc.
  • InspireMD Inc.
  • Johnson & Johnson Services Inc.
  • Kaneka Corporation
  • Lepu Medical Technology Co. Ltd.
  • Medtronic Plc
  • Merlin MD Pte. Ltd.
  • MicroPort Scientific Corporation
  • MicroVention Inc.（Terumo）
  • Mizuho Medical Co., Ltd.
  • Oxford Endovascular Ltd.
  • Penumbra Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Sequent Medical Inc.
  • Siemens AG
  • Stryker Corporation
  • Terumo Corporation
  • Wallaby Medical LLC
  • W.L. Gore & Associates, Inc.

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP36915

Global Flow Diversion Aneurysm Treatment Market to Reach US$8.2 Billion by 2030

The global market for Flow Diversion Aneurysm Treatment estimated at US$5.3 Billion in the year 2024, is expected to reach US$8.2 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Flow-Diverting Stents, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Intrasaccular Flow Disruption Devices segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 7.6% CAGR

The Flow Diversion Aneurysm Treatment market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.9% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Flow Diversion in Aneurysm Treatment - Key Trends & Drivers Summarized

Why Is Flow Diversion Transforming the Management of Intracranial Aneurysms?

Flow diversion has emerged as a breakthrough technique in the treatment of intracranial aneurysms, particularly for wide-neck, large, fusiform, and previously untreatable aneurysms that pose challenges for conventional clipping or coiling methods. Unlike traditional endovascular coiling that fills the aneurysm sac directly, flow diverters are stent-like devices implanted within the parent artery to redirect blood flow away from the aneurysm. This promotes intra-aneurysmal thrombosis and vascular remodeling, leading to gradual occlusion and long-term stabilization of the aneurysm wall.

The minimally invasive nature of this approach, combined with its efficacy in complex and unruptured aneurysms, has positioned flow diversion as a preferred strategy in neurointervention. Clinical adoption has surged in response to increasing awareness of its favorable long-term outcomes, reduced retreatment rates, and applicability to challenging anatomical regions such as the internal carotid artery. As neurological imaging and intervention capabilities evolve, flow diversion is being integrated into early-stage treatment planning, especially for aneurysms previously considered inoperable.

What Innovations Are Enhancing the Efficacy and Safety of Flow Diverters?

Technological advancements in flow diverter design and delivery systems are playing a critical role in improving procedural outcomes and safety profiles. The latest generation of flow diverters features lower-profile systems compatible with smaller microcatheters, allowing for better navigability through tortuous intracranial vasculature. Innovations such as resheathable and repositionable devices give neurointerventionists greater control during deployment, reducing the risk of malposition or vessel injury.

Surface modifications and anti-thrombotic coatings-such as phosphorylcholine or hydrophilic polymer coatings-are being adopted to enhance hemocompatibility and reduce reliance on long-term dual antiplatelet therapy. Some next-gen flow diverters are even bioresorbable, designed to degrade once vascular remodeling is achieved, minimizing long-term implant risks. Additionally, imaging-guided navigation systems, including 3D rotational angiography and roadmap fluoroscopy, are improving the precision and confidence of device placement. These innovations are enabling treatment of aneurysms in previously inaccessible or high-risk locations, including distal vessels and bifurcation points.

Which Patient Populations and Clinical Settings Are Driving Demand for Flow Diversion?

Flow diversion is most commonly employed for unruptured intracranial aneurysms in adult patients, particularly in the anterior circulation (e.g., internal carotid artery). However, growing clinical evidence is expanding its use in posterior circulation aneurysms, recurrent aneurysms post-coiling, and selected cases of ruptured aneurysms under compassionate use or advanced center protocols. The approach is especially beneficial for patients with large or giant aneurysms, where coiling would be less effective or technically challenging.

Tertiary and quaternary care centers equipped with specialized neurointerventional capabilities are the primary sites of adoption, although the technique is gradually being disseminated to regional and community hospitals as training and device availability improve. Increased detection of asymptomatic aneurysms through incidental brain imaging is also contributing to earlier intervention using flow diversion. Meanwhile, aging populations and increasing stroke awareness are expanding the eligible patient base, as early identification and elective treatment of aneurysms gain clinical traction.

What Are the Primary Drivers Supporting Growth in the Flow Diversion Market?

The growth in the flow diversion aneurysm treatment market is driven by several key factors related to procedural efficacy, clinical demand, and product innovation. A major driver is the expanding body of real-world evidence and long-term follow-up data demonstrating high occlusion rates, low retreatment needs, and favorable neurological outcomes. As neurointervention shifts toward minimally invasive solutions with durable results, flow diversion aligns well with both clinician and patient expectations.

In parallel, improvements in device flexibility, deliverability, and safety features are broadening the anatomical range and complexity of aneurysms that can be treated with flow diversion. Rising investments in stroke and neurovascular intervention infrastructure-particularly in emerging economies-are also facilitating broader access to advanced aneurysm therapies. Moreover, continuous training, proctoring, and certification programs by device manufacturers and academic centers are accelerating clinical adoption. Together, these drivers are reinforcing flow diversion as a cornerstone technique in the next-generation management of cerebral aneurysms.

SCOPE OF STUDY:

The report analyzes the Flow Diversion Aneurysm Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Flow-Diverting Stents, Intrasaccular Flow Disruption Devices); End-Use (Hospitals End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Acandis GmbH
  • BALT Group
  • Cardinal Health Inc.
  • Endologix LLC
  • Evasc Medical Systems Corp.
  • Imperative Care Inc.
  • InspireMD Inc.
  • Johnson & Johnson Services Inc.
  • Kaneka Corporation
  • Lepu Medical Technology Co. Ltd.
  • Medtronic Plc
  • Merlin MD Pte. Ltd.
  • MicroPort Scientific Corporation
  • MicroVention Inc. (Terumo)
  • Mizuho Medical Co., Ltd.
  • Oxford Endovascular Ltd.
  • Penumbra Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Sequent Medical Inc.
  • Siemens AG
  • Stryker Corporation
  • Terumo Corporation
  • Wallaby Medical LLC
  • W.L. Gore & Associates, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Flow Diversion Aneurysm Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Complex Cerebral Aneurysms Spurs Demand for Flow Diversion Therapies
    • Technological Advancements in Stent Design Enhance Efficacy and Safety of Flow Diverters
    • Growing Preference for Minimally Invasive Endovascular Procedures Drives Adoption in Neurointervention
    • Expansion of Neurovascular Specialty Clinics Strengthens Business Case for Flow Diversion Devices
    • Improved Outcomes in Wide-Neck and Large Aneurysms Accelerate Clinical Acceptance
    • Integration of Imaging-Guided Placement Techniques Enhances Procedural Precision
    • Development of Next-Generation Bioactive Coatings Improves Endothelialization Rates
    • Increasing Aging Population with Vascular Disorders Propels Demand for Endovascular Solutions
    • Growth in Hybrid Operating Rooms Facilitates Deployment of Advanced Neurointervention Tools
    • Rising Adoption of Dual Antiplatelet Therapy Compliance Tools Supports Treatment Safety
    • Surge in Stroke Awareness Programs Enhances Diagnosis and Referral Rates for Aneurysm Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Flow Diversion Aneurysm Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Flow Diversion Aneurysm Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Flow-Diverting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Flow-Diverting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Intrasaccular Flow Disruption Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Intrasaccular Flow Disruption Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Flow Diversion Aneurysm Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 13: USA 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 14: USA Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 17: Canada 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Canada 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • JAPAN
    • Flow Diversion Aneurysm Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Japan 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • CHINA
    • Flow Diversion Aneurysm Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 24: China Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: China 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 26: China Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • EUROPE
    • Flow Diversion Aneurysm Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 28: Europe Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: Europe 6-Year Perspective for Flow Diversion Aneurysm Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Europe 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • FRANCE
    • Flow Diversion Aneurysm Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 34: France Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: France 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 36: France Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: France 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • GERMANY
    • Flow Diversion Aneurysm Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Germany 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • ITALY
    • TABLE 42: Italy Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Italy 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • UNITED KINGDOM
    • Flow Diversion Aneurysm Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 46: UK Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: UK 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 48: UK Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: UK 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Flow Diversion Aneurysm Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Asia-Pacific 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by Product - Flow-Diverting Stents and Intrasaccular Flow Disruption Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of World 6-Year Perspective for Flow Diversion Aneurysm Treatment by Product - Percentage Breakdown of Value Sales for Flow-Diverting Stents and Intrasaccular Flow Disruption Devices for the Years 2025 & 2030
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Flow Diversion Aneurysm Treatment by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of World 6-Year Perspective for Flow Diversion Aneurysm Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2025 & 2030

IV. COMPETITION